By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


Teva Pharmaceutical Industries Ltd. develops, produces and markets ethical drugs, generic drugs, and fine chemicals for the pharmaceutical industry and disposable products for hospitals and home care services.




Founders: Chaim Salomon, Moshe Levin, and Yitschak Elstein

CEO: Erez Vigodman

CEO Global Operations: Carlo de Notaristefani

CEO Global Specialty Medicines: Rob Koremans

CEO Global Generic Medicines: Sigudur (Siggi) Olafsson

CFO: Eyal Desheh

CMO (Medical):

CSO (Scientific): Michael Hayden


Please click here for Teva Pharma job opportunities.


Please click here for clinical trial information.


All Products

Key Statistics

Ownership: Public

Web Site: Teva
Employees: 5,700
Symbol: TEVA


Company News
Teva (TEVA) Ordered To Pay GlaxoSmithKline (GSK) $235 Million In Coreg Patent Row 6/23/2017 6:15:11 AM
Teva (TEVA), USA Extends Voluntary Nationwide Recall To Consumer/User Level For One Lot Of Paliperidone ER Tablets, 3mg, 90 Count Bottles Distributed Under The Actavis Pharma Inc. Label Due To Dissolution Test Failure 6/15/2017 11:01:42 AM
AbCellera Biologics Announces Expanded Research Collaboration With Teva (TEVA) 6/13/2017 8:10:27 AM
Teva (TEVA) Announces Launch Of Generic Zetia In The United States 6/13/2017 7:47:49 AM
Teva (TEVA) Announces Exclusive Launch Of Generic Pataday In The United States 6/9/2017 8:37:24 AM
Struggling Teva (TEVA) Wants To Overhaul Board By Nominating 4 New Directors 6/9/2017 6:31:26 AM
How This Small Washington Biotech Stands To Outperform Rivals Amgen (AMGN), Eli Lilly (LLY) And Teva (TEVA) In Migraine Drugs 6/9/2017 6:04:01 AM
Teva (TEVA)'s Fremanezumab Meets All Primary & Secondary Endpoints Across Both Monthly And Quarterly Dosing Regimens 6/7/2017 7:54:09 AM
Teva (TEVA) To Present Data From 18 Abstracts In Tardive Dyskinesia And Huntington Disease At The 21st International Congress Of Parkinson’s Disease And Movement Disorders 6/1/2017 8:36:32 AM
Teva (TEVA) Announces Positive Results For Phase III Study Of Fremanezumab For The Prevention Of Chronic Migraine 5/31/2017 9:43:11 AM